Billions More in M&A, Another Bidding War and More FDA Drama

How Biotech Funding is Changing Executive Search and Hiring Processes

Pfizer Wins Metsera, Trump Strikes GLP-1 Pricing Deal, FDA Awards More Priority Vouchers

Thoughtful Tech: How Removing Technological Burdens Can Improve Clinical Trial Compliance and Patient Experience

Pfizer and Novo Battle Over Metsera, Tidmarsh Fights FDA Exit, UniQure and Sarepta Face Setbacks

Innovation, Resilience, and the Future of Global Manufacturing

Novartis’ Big Buy, Q3 Earnings, Regeneron’s Dropped Cell Therapy, More

How Supply Chain Turbulence is Reshaping Biotech Strategy

Novo Board Upended, ESMO Excitement, FDA Awards, Replimune’s U-Turn

Cost Control to Capability Building: Rethinking Supply and Strategy in Pharma

Work Smart, Build Trust: Connecting Technology, Patient Compliance and Data Processing

Q3 Earnings Are Here, Novo Ditches Cell Therapy but Buys Akero, Gov’t Shutdown Hits CDC

Bonus: Q3 2025 Job Market Update

Shutdown Pauses New Drug Reviews, CDC Issues New COVID Guidance, CGT Meets on Mesa

Hit Me With Your Best Shot: Understanding Autoinjectors and Combination Drug Delivery Systems

M&A Picks Up, Walmsley Moves On, Pfizer’s MFN Deal and Hope for Huntington’s

FDA’s Autism Endeavor, Pfizer’s Obesity Comeback Bid, Psychedelics Revival, ACIP Confusion, More

What Do AI and Hammers Have in Common?

China Crackdown, UK Exit, Novo Layoffs, Adcomm Flip Flop, More

Unpacking the Latest MAHA Report, RFK’s Senate Appearance, FDA’s CRL Drop and More